By Kelly A. Briganti, Editorial Director, G2 Intelligence
The U.S. Department of Health and Human Services (HHS), its Office of Inspector General, the Federal Bureau of Investigation, and the Justice Department's Criminal Division announced a nationwide "takedown" of 243 individuals in connection with an alleged Medicare fraud scheme involving more than $700 million in false billings. The individuals charged include…
Read more...
By Stephanie Murg, Managing Director, G2 Intelligence
With "precision medicine" and "personalized medicine" initiatives in the spotlight, the American Association for Clinical Chemistry (AACC) is looking to seize the momentum with a call for policies that ensure access to and appropriate reimbursement for tests that enable tailored treatment. The organization's position paper, issued…
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Rapid diagnosis of infectious pathogens is key to controlling outbreaks. Time to diagnosis is particularly critical for deadly infections such as Ebola. The U.S. Department of Health and Human Services' (HHS') office for preparedness and response announced a $1.8 million contract with OraSure Technologies (Bethlehem, Penn.) for further development of a…
Read more...
By Ron Shinkman, Editor, Laboratory Industry Report
The University of California, San Francisco (UCSF) and Kaiser Permanente have concluded that a blood or urine-based laboratory test may be developed that can determine a patient's genetic risk for developing prostate cancer…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
In the effort to reduce unnecessary utilization and health care costs and focus on quality and value, pre-operative testing has been receiving significant attention. In last week's Insider, we highlighted a study indicating that guidance addressing overutilization of preoperative testing had not led to a significant decrease in…
Read more...
|
